Larson Financial Group’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$300 Sell
2
-11
-85% -$1.2K ﹤0.01% 3565
2026
Q1
$1.2K Buy
+13
New +$1.3K ﹤0.01% 3096
2025
Q2
Sell
-6
Closed -$256 3364
2025
Q1
$256 Buy
+6
New +$259 ﹤0.01% 2734
2023
Q4
Sell
-28
Closed -$830 1842
2023
Q3
$830 Buy
+28
New +$985 ﹤0.01% 1516

Other funds holding GH

Larson Financial Group's GH Position: Q2 2026 in Review

Larson Financial Group reduced its Guardant Health (GH) stake by 85% in Q2 2026, selling an estimated $1.2K and leaving 2 shares worth $300. The position accounts for ﹤0.01% of the portfolio, ranked #3565.

Larson Financial Group first reported a position in GH in Q3 2023 and has held it in 4 quarters since. The position peaked at $1.2K in Q1 2026. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Larson Financial Group held 2 shares of Guardant Health worth $300 as of Q2 2026.
  • Larson Financial Group sold 11 Guardant Health shares in Q2 2026, an estimated $1.2K.
  • Guardant Health made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3565 holding.
  • Larson Financial Group first reported a position in Guardant Health in Q3 2023 and has held it in 4 quarters since.
  • Larson Financial Group's Guardant Health position peaked at $1.2K in Q1 2026.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.